SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001308179-24-000207
Filing Date
2024-03-21
Accepted
2024-03-21 07:32:28
Documents
10

Document Format Files

Seq Description Document Type Size
1 VERICEL CORP - DEFA14A lvcel2024-defa14a.htm DEFA14A 32922
2 GRAPHIC check01.jpg GRAPHIC 1441
3 GRAPHIC logo.jpg GRAPHIC 12342
4 GRAPHIC lvcel2024x1x1.jpg GRAPHIC 60911
5 GRAPHIC lvcel2024x1x2.jpg GRAPHIC 5290
6 GRAPHIC lvcel2024x1x3.jpg GRAPHIC 4574
7 GRAPHIC lvcel2024x1x4.jpg GRAPHIC 7360
8 GRAPHIC lvcel2024x1x5.jpg GRAPHIC 6842
9 GRAPHIC lvcel2024x1x6.jpg GRAPHIC 1098
10 GRAPHIC uncheck.jpg GRAPHIC 1060
  Complete submission text file 0001308179-24-000207.txt   174261
Mailing Address 64 SIDNEY ST. CAMBRIDGE MA 02139
Business Address 64 SIDNEY ST. CAMBRIDGE MA 02139 7349305555
Vericel Corp (Filer) CIK: 0000887359 (see all company filings)

IRS No.: 943096597 | State of Incorp.: MI | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35280 | Film No.: 24769453
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)